The use of albuterol/budesonide as reliever therapy to reduce asthma exacerbations.
Anti-inflammatory reliever
As-needed
Flares
Inhaled corticosteroids
Nongenomic
Reliever
Rescue
Short-acting beta-2-agonist
Journal
The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220
Informations de publication
Date de publication:
03 Feb 2024
03 Feb 2024
Historique:
received:
05
06
2023
revised:
18
12
2023
accepted:
17
01
2024
medline:
6
2
2024
pubmed:
6
2
2024
entrez:
5
2
2024
Statut:
aheadofprint
Résumé
Prevention of asthma exacerbations and reduction of systemic corticosteroid burden remain unmet needs in asthma. US asthma guidelines recommend concomitant short-acting β
Identifiants
pubmed: 38316182
pii: S2213-2198(24)00145-4
doi: 10.1016/j.jaip.2024.01.043
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.